Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies
Authors:
- 27 February 2012
- journal article
- research article
- Published by Wiley in Brain Pathology
- Vol. 22 (6) , 745-756
Abstract
A key component in Lewy body (LB) pathology in LB disorders is α‐synuclein phosphorylated at serine 129 (pαsyn). However, it is not known if increase in the level of biochemically measurable pαsyn precedes the presence of histologically identified Lewy‐type synucleinopathy (LTS). To gain sights into possible temporal sequence, we measured levels of pαsyn in cingulate and temporal cortices that develop LTS pathology at later stages of LB disorders. Brain homogenates from 128 autopsy cases including normal controls and subjects classified by Unified LTS histopathology staging system were studied. We found that biochemically measurable pαsyn levels in cingulate and temporal cortices were significantly increased at Unified stages III and IV. When pαsyn levels were compared between LTS density scores instead of Unified stages, significant increases were detected even as LTS density scores increased from 0 to 1 in olfactory bulb and substantia nigra. Therefore, our findings demonstrated that changes of pαsyn levels in cingulate and temporal cortices coincided with the early appearance of the LTS pathology in olfactory bulb and substantia nigra, even though histologically demonstrable LTS was lacking in the cortical region. Therefore, identifying the underlying mechanisms driving these changes could be crucial to understanding the pathogenesis of LB disorders.Keywords
This publication has 57 references indexed in Scilit:
- Phosphorylated α-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent MannerJournal of Biological Chemistry, 2010
- Phosphorylation of Synucleins by Members of the Polo-like Kinase FamilyJournal of Biological Chemistry, 2010
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionActa Neuropathologica, 2009
- Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disordersActa Neuropathologica, 2008
- A critical evaluation of the Braak staging scheme for Parkinson's diseaseAnnals of Neurology, 2008
- Evaluation of α-synuclein immunohistochemical methods used by invited expertsActa Neuropathologica, 2008
- The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007Cell and Tissue Banking, 2008
- Applicability of current staging/categorization of α-synuclein pathology and their clinical relevanceActa Neuropathologica, 2008
- The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson diseaseProceedings of the National Academy of Sciences, 2008
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998